The phase 3 DELTA TEEN trial evaluating Anzupgo 20 mg/g cream for the treatment of chronic hand eczema in adolescents has shown positive results, LEO Pharma announced in a press release. The 16-week, ...
Prescriptions for a range of ‘over the counter’ remedies are no longer available on the NHS after a crackdown in recent years ...
11h
Investor's Business Daily on MSNArcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...
16h
Hosted on MSNHives vs. Eczema: What's the Difference?Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...
For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results